American tariffs and fears of a prolonged recession have increased calls to expand resource development and infrastructure ...

The trial will be decentralised and open to eligible individuals throughout the Canadian province of British Columbia (BC). Participants will be recruited through the province-wide Post-COVID-19 ...

Objective To evaluate the impact of a personalised audit and feedback prescribing report (AF) and brief educational summary (ES) on empiric treatment of uncomplicated lower urinary tract infections ...

A target trial using observational data will be emulated to determine the effectiveness of different initiation times of methadone take-home doses as observed in clinical practice in British Columbia.

Vancouver, British Columbia-- (Newsfile Corp. - February 6, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neurorestorative ...

The future of clinical trials is one of both challenge and opportunity. Sponsors who embrace the shifts in compliance, data integrity, collaboration, and technology adoption will be well-positioned to ...

A phase II trial for patients with traumatic brain injury (TBI) will aim to break the impasse of 30 years of failed clinical trials for TBI. The study will compare the effects of off-label drugs that ...

The Clinical Trial Modernization Act is a concrete step toward easing the financial burdens people may face when enrolling in clinical trials.

Clinical trials are frightening endeavors for biotech investors. Expensive and fraught with risk, a trial’s failure can seriously lighten an investor’s pockets with little hope of recourse ...

The trial is studying clinical oral immunotherapy treatments in which patients are given small doses of the food to which they are allergic to build up their tolerance.

This is a first-of-its-kind clinical trial investigating the potential of cannabidiol (CBD) as a treatment for bipolar depression.

British Columbia has announced a new regional clinical trials unit (CTU) to be based out of a Vancouver hospital priced at $4.2m.